How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases

European Journal of Cancer Part A

Volumn 32, Issue 14, 1996, Pages 2430-2437

  Polverini, P J ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

EID: 0030498694     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00386-3     Document Type: Article

References (70)

1. 1. Folkman J, Cotran RS. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976, 16, 207-248.
2. 2. Folkman J. Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med 1985, 9, 10-36.
3. 3. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987, 235, 442-447.
4. 4. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995, 6, 230-247.
5. 5. Madri JA, Williams SK. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol 1983, 97, 153-165.
6. 6. Ingber DE, Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 1989, 109, 317-330.
7. 7. Klagsbrun M. Regulators of angiogenesis: stimulators, inhibitors, and extracellular matrix. J Cell Biochem 1991, 47, 199-200.
8. 8. Ingber DE. Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy. Cancer Biol 1992, 3, 57-63.
9. 9. Ingber D. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem 1991, 47, 236-241.
10. 10. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1982, 14, 53-65.
11. 11. Vlodavsky I, Fuks Z, Ashai-Michaeli R, et al. Extracellular matrix-resident basic fibroblast growth factor: implications for control of angiogenesis. J Cell Biochem 1991, 47, 167-176.
12. 12. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M. Transforming growth factor Beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 1993, 155, 595-605.
13. 13. Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE. Convergence of integrin and growth factor receptor signaling pathways within focal adhesion complex. Mol Biol Cell 1995, 6, 1349-1365.
14. 14. Brooks PC, Stromblad S, Sanders LC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85, 1-20.
15. 15. Merwin JR, Anderson JM, Kocher O, Van Itallie CM, Madri JA. Transforming growth factor beta-1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 1990, 142, 117-128.
16. 16. Frank R, Adelmann-Grill BC, Herrmann K, Haustein UF, Petri JB, Heckmann M. Transforming growth factor-β controls cell-matrix interactions of microvascular dermal endothelial cells by downregulation of integrin expression. J Invest Dermatol 1996, 106, 36-41.
17. 17. Ingber DE, Madri JA, Folkman J. Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion in vitro. Cell Devel Biol 1987, 23, 387-394.
18. 18. Singhvi R, Kumar A, Lopez GP, et al. Engineering cell shape and function. Science 1994, 264, 696-698.
19. 19. Ingber DE, Prusty D, Sun Z, Betensky H, Wang N. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. J Biomechanics 1995, 28, 1471-1484.
20. 20. Ingber DE, Folkman J. How does extracellular matrix control capillary morphogenesis. Cell 1989, 58, 803-805.
21. 21. Montesano R. Regulation of angiogenesis in vitro. Eur J Clin Invest 1992, 22, 504-515.
22. 22. Montesano R, Orci L, Vassalli P. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 1983, 97, 1648-1652.
23. 23. Montesano R, Pepper MS, Belin D, Vassalli JD, Orci L. Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 1987, 132, 509-516.
24. 24. Iruela-Arispe ML, Hasselaar, Sage H. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 1991, 64, 174-185.
25. 25. Iruela-Arispe ML, Diglio CA, Sage H. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arteriosclerosis Thrombosis 1991, 11, 805-815.
26. 26. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985, 230, 1375-1378.
27. 27. Ingber DE, Madri JA, Folkman J. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 1986, 119, 1768-1775.
28. 28. Ingber DE, Folkman J. Inhibition of angiogenesis through inhibition of collagen metabolism. Lab Invest 1988, 59, 44-51.
29. 29. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1988, 107, 1589-1598.
30. 30. Jaye M, McConathy E, Drohan W, Tong B, Deuel T, Maciag T, Modulation of the sis gene transcript during endothelial cell differentiation in vitro. Science 1985, 228, 882-884.
31. 31. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization form cartilage. Science 1990, 248, 1408-1410.
32. 32. Mignatti P, Tusboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 1988, 108, 671-682.
33. 33. Levin EG, Santell N. Association of plasminogen activator inhibitor (PAI 1) with the growth substratum of human endothelial cells. J Cell Biol 1987, 105, 2543-2549.
34. 34. Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 1990, 111, 743-755.
35. 35. Johnson MD, Kim H-RC, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994, 160, 194-202.
36. 36. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994, 162, 499-510.
37. 37. Polverini PJ, Nickoloff BJ. Role of scatter factor and the c-met protooncogenes in the pathogenesis of AIDS-associated Kaposi's sarcoma. Adv Cancer Res 1995, 66, 235-253.
38. 38. Rutgers JL, Weiczorek R, Bonetti F, et al. The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma: evidence for a vascular endothelial cell origin. Am J Pathol 1986, 122, 493-499.
39. 39. Roth WK, Werner S, Risau W, Remberger K, Hofschneider PH. Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro. Int J Cancer 1988, 42, 767-773.
40. 40. Zhang Y-M, Bachmann S, Hemmer C, et al. Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol 1994, 144, 51-59.
41. 41. Naidu YM, Rosen EM, Zitnick R, et al. Role of scatter factor in the pathogenesis of AIDS-related Kaposi's sarcoma. Proc Natl Acad Sci USA 1994, 91, 5281-5285.
42. 42. Polverini PJ, Cotran RS, Gimbrone Jr MA, Unanue ER. Activated macrophages induce vascular proliferation. Nature 1977, 269, 804-806.
43. 43. Sunderkotter C, Goebeler M, Schultze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther 1991, 51, 195-216.
44. 44. DiPietro LA, Polverini PJ. Role of the macrophage in the positive and negative regulation of wound neovascularization. Behring Inst Mitt 1993, 92, 238-247.
45. 45. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leucocyte Biol 1994, 55, 410-422.
46. 46. Polverini JJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial cell proliferation in vitro by tumor-associated macrophages. Lab Invest 1984, 51, 635-642.
47. 47. Polverini PJ. Macrophage-induced angiogenesis: a review. In Sorg C, ed. Macrophage-Derived Regulatory Factors. Basel, Karger, 1989, 54-73.
48. 48. Lawler J. The structural and functional properties of thrombospondin. Blood 1986, 67, 1197-1209.
49. 49. Sage H, Bornstein P. Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 1991, 266, 14831-14834.
50. 50. Frazier WA. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol 1987, 105, 625-632.
51. 51. Frazier WA. Thrombospondin. Curr Opin Cell Biol 1991, 3, 792-799.
52. 52. Bornstein P. Diversity of function is inherent in matrix proteins: an appraisal of thrombospondin 1. J Cell Biol 1995, 130, 503-506.
53. 53. Good DJ, Polverini PJ, Rastinejad F, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990, 87, 6624-6628.
54. 54. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989, 56, 345-355.
55. 55. O'Shea KS, Dixit VM. Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 1988, 107, 2737-2748.
56. 56. Sage H, Bornstein P. Endothelial cells from umbilical vein and a hemangioendothelioma secrete basement membrane largely to the exclusion of interstitial procollagens. Arteriosclerosis 1982, 2, 27-36.
57. 57. DiPietro LA, Nebgen DR, Polverini PJ. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res 1994, 31, 178-185.
58. 58. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ. Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 1996, 148, 1851-1860.
59. 59. Polverini PJ, DiPietro LA, Dixit VM, Hynes RO, Lawler J. Thrombospondin 1 knockout mice show delayed organization and neovascularization of skin wounds. FASEB 1995, 9, 272a.
60. 60. DiPietro LA, Polverini PJ. Angiogenic macrophages produce the angiogenesis inhibitor thrombospondin 1. Am J Pathol 1994, 143, 678-684.
61. 61. Mantovani A. Biology of disease. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vitro function of chemokines. Lab Invest 1994, 71, 5-16.
62. 62. Lingen MW, Polverini PJ, Bouck N. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lab Invest 1996, 74, 476-483.
63. 63. Lingen MW, Polverini PJ, Bouck N. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol 1996, 149, 247-258.
64. 64. Farber EM, Nall ML, Watson W. Natural history of psoriasis in 61 twin pairs. Arch Dermatol 1974, 109, 207-211.
65. 65. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol 1991, 127, 871-884.
66. 66. Wolfe Jr JE, Hubler Jr WR. Angiogenesis in psoriasis. In Farber E, Cox A, eds. Psoriasis: Proceedings of the Second International Symposium. New York, York Medical Books, 1976, 375-377.
67. 67. Wolfe JE, Angiogenesis in normal and psoriatic skin. Lab Invest 1989, 61, 139-142.
68. 68. Malhotra R, Stenn KS, Fernandez LA, Braverman IM. Angiogenic properties of normal and psoriatic skin associated with epidermis, not dermis. Lab Invest 1989, 61, 162-165.
69. 69. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994, 144, 820-828.
70. 70. Nickoloff BJ, Riser BL, Mitra RS, Dixit VM, Varani J. Inhibitory effect of gamma interferon on cultured keratinocytes thrombospondin production, distribution, and biological activity. J Invest Dermatol 1988, 91, 213-218.